Press Release

Global Sales Of Swine Vaccines Expected $1176 Million In 2017

Date : Dec 06, 2018

In the last several years, global market of Swine Vaccines developed steadily, with an average growth rate of 4.25%. In 2017, global sales revenue of Swine Vaccines is nearly 1176 M USD; the actual sale is about 9.34 billion doses.

The classification of Swine Vaccines includes CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines and Other Vaccines. The proportion of T CSF Vaccines in 2017 is about 44%.

Swine Vaccines is application in Government Tender and Market Sales. The most of Swine Vaccines are Market Sales, and the market share in 2017 is about 89%.

China is the largest consumption place, with a consumption market share nearly 56% in 2017. Following China, Europe is the second largest consumption place with the consumption market share of 19% in 2017.

Market competition is intense Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio,Chopper Biology etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Swine Vaccines industry will be more and more popular in the future.

The Global Swine Vaccines Market Research Report 2018 This report released by we provides a basic overview of the Swine Vaccines industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.

The report then focuses on major industry players in global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Swine Vaccines industry development trends and marketing channels were analyzed.Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.

Would like to place an order or any question, please feel free to contact at  &

Contact No: +13474743864